Key result
Donor genetic predisposition linked to progressive allograft ApHCM 11 years after orthotopic heart transplantation.
Case Report (n=1)
No
This case highlights the rare development of apical hypertrophic cardiomyopathy in a transplanted heart, emphasizing the potential role of donor genetic predisposition in long-term post-transplant complications.
Answers are grounded in this paper and cite their sources.
Rare apical HCM in allografts may reflect donor predisposition; hypothesis-generating and should not yet alter surveillance or donor selection.
In this case study, we present the evaluation of an orthotopic heart transplant (OHT) patient who presented with persistent shortness of breath and dizziness upon standing. The investigation uncovered the presence of progressive hypertrophic cardiomyopathy (HCM) in the transplanted heart, a condition first detected 11 years after the transplantation. Utilizing echocardiography with global longitudinal strain (GLS), we determined that the HCM likely originated from genetic predominance inherited from the heart donor rather than hypertensive disease. This finding highlights the significance of genetic factors in post-transplant complications and warrants further investigation into the long-term effects of heart transplantation on recipient health.
No takes yet. Share an insight, caveat, or question.
Molina-Lopez et al. (2023) conducted a case report in Apical Hypertrophic Cardiomyopathy (n=1). Beta-blocker therapy was evaluated on Development of Apical Hypertrophic Cardiomyopathy. A 75-year-old male orthotopic heart transplant recipient developed progressive apical hypertrophic cardiomyopathy in the allograft 11 years post-transplantation, likely due to donor genetic predisposition.
Synapse has enriched 10 related papers. Consider them for comparative context: